Aridis Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aridis Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2022.
  • Aridis Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $200K, a 42.7% decline year-over-year.
  • Aridis Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $862K, a 52.7% decline year-over-year.
  • Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.48M, a 34.3% decline from 2021.
  • Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.25M, a 5.78% increase from 2020.
  • Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $2.13M, a 10.4% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.48M -$772K -34.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-05-22
2021 $2.25M +$123K +5.78% Jan 1, 2021 Dec 31, 2021 10-K 2023-05-22
2020 $2.13M +$200K +10.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-13
2019 $1.93M +$402K +26.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $1.53M Jan 1, 2018 Dec 31, 2018 10-K 2020-04-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.